Management of access site and systemic complications of percutaneous coronary and peripheral interventions

Journal of Invasive Cardiology

Volumn 20, Issue 9, 2008, Pages 463-469

  Kiernan, Thomas J ^b   Ajani, Andrew E ^b   Yan, Bryan P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; AMINOGLYCOSIDE; ANTICOAGULANT AGENT; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; DIGOXIN; DOPAMINE; FENOLDOPAM; FIBRINOLYTIC AGENT; HEPARIN; ILOPROST; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTAMINE; STEROID; THROMBIN;

ARTERIOVENOUS FISTULA; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR PROCEDURES; CAROTID ARTERY DISEASE; CHOLESTEROL EMBOLISM; COMPRESSION THERAPY; CONTRAST MEDIUM INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DRUG SAFETY; FALSE ANEURYSM; HEMATOMA; HUMAN; IATROGENIC DISEASE; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; RETROPERITONEAL HEMATOMA; REVIEW; STROKE; SYSTEMIC DISEASE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANEURYSM, FALSE; ANGIOPLASTY, BALLOON; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; HEMATOMA; HUMANS; PERIPHERAL VASCULAR DISEASES; STROKE; VENOUS THROMBOSIS;

EID: 50849095146     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Stedman's Medical Dictionary, 25th edition. Baltimore, MD: Williams and Wilkins, 2001.
2. Kresowik TF, Khoury MD, Miller BV, et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg 1991;13:328-333.
3. Lumsden AB, Miller JM, Kosinski AS, et al. A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. Am Surg 1994;60:132-137.
4. Toursarkissian B, Allen BT, Petrinec D, et al. Spontaneous closure of selected iatrogenic pseudoaneurysms and arteriovenous fistulae. J Vasc Surg 1997;25:803-808.
5. Fellmeth BD, Roberts AC, Bookstein JJ, et al. Postangiographic femoral artery injuries: Nonsurgical repair with US-guided compression. Radiology 1991;178:671-675.
6. Hood DB, Mattos MA, Douglas MG, et al. Determinants of success of color-flow duplex-guided compression repair of femoral pseudoaneurysms. Surgery 1996;120:585-588.
7. Birchall D, Fields JM, Chalmers N, Walker MG. Case report: Delayed superficial femoral artery pseudoaneurysm rupture following successful compression therapy. Clin Radiol 1997;52:629-630.
8. Cope C, Zeit R. Pseudoaneurysms after nephrostomy. AJR Am J Roentgenol 1982;139:255-261.
9. Cope C, Zeit R. Coagulation of aneurysms by direct percutaneous thrombin injection. AJR Am J Roentgenol 1986;147:383-387.
10. Hanson JM, Atri M, Power N. Ultrasound-guided thrombin injection of iatrogenic groin pseudoaneurysm: Doppler features and technical tips. Br J Radiol 2008;81:154-163.
11. Schneider C, Malisius R, Küchler R, et al. A prospective study on ultrasound-guided percutaneous thrombin injection for treatment of iatrogenic post-catheterisation femoral pseudoaneurysms. Int J Cardiol 2008 Jan 11. [Epub ahead of print].
12. Kang SS, Labropoulos N, Mansour MA, et al. Expanded indications for ultrasound-guided thrombin injection of pseudoaneurysms. J Vasc Surg 2000;31:289-298.
13. La Perna L, Olin JW, Goines D, et al. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation 2000;102:2391-2395.
14. Johnson A, Tahamont MV, Kaplan JE, Malik AB. Lung fluid balance after pulmonary embolization: Effects of thrombin vs. fibrin aggregates. J Appl Physiol 1982;52:1565-1570.
15. Arfors KE, Busch C, Jakobson S, et al. Pulmonary insufficiency following intravenous infusion of thrombin and AMCA (tranexamic acid) in the dog. Acta Chir Scand 1972;138:445-452.
16. Williams SG, Peters RA, Westaby D. Thrombin - An effective treatment for gastric variceal haemorrhage. Gut 1994;35:1287-1289.
17. Kang SS, Labropoulos N, Mansour MA, Baker WH. Percutaneous ultrasound guided thrombin injection: A new method for treating postcatheterization femoral pseudoaneurysms. J Vasc Surg 1998;27:1032-1038.
18. Sheiman RG, Brophy DP. Treatment of iatrogenic femoral pseudoaneurysms with percutaneous thrombin injection: Experience in 54 patients. Radiology 2001;219:123-127.
19. Mohler ER 3rd, Mitchell ME, Carpenter JP, et al. Therapeutic thrombin injection of pseudoaneurysms: A multicenter experience. Vasc Med 2001;6:241-244.
20. D'Ayala M, Smith R, Zanieski G, et al. Acute arterial occlusion after ultrasound-guided thrombin injection of a common femoral artery pseudoaneurysm with a wide, short neck. Ann Vasc Surg 2008;22:473-475.
21. Mak GY, Daly B, Chan W, et al. Percutaneous treatment of post catheterization massive retroperitoneal hemorrhage. Cathet Cardiovasc Diagn 1993;29:40-43.
22. Silva JA, Stant J, Ramee SR. Endovascular treatment of a massive retroperitoneal bleeding: Successful balloon-catheter delivery of intra-arterial thrombin. Catheter Cardiovasc Interv 2005;64:218-222.
23. Dabney A, Bastani B. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: A report of two cases. Intensive Care Med 2001;27:1954-1957
24. Kelm M, Perings SM, Jax T, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: Implications for risk stratification and treatment. J Am Coll Cardiol 2002;40:291-297.
25. Glaser RL, McKellar D, Scher KS. Arteriovenous fistulas after cardiac catheterization. Arch Surg 1989;124:1313-1315.
26. Perings SM, Kelm M, Jax T, Strauer BE. A prospective study on incidence and risk factors of arteriovenous fistulae following transfemoral cardiac catheterization. Int J Cardiol 2003;88:223-228.
27. Paulson EK, Kliewer MA, Hertzberg BS, et al. Ultrasonographically guided manual compression of femoral artery injuries. J Ultrasound Med 1995;14:653-659.
28. Ovroutski S, Ewert P, Schubel J, et al. A rare complication of laparoscopic surgery: Itrogenic arteriovenous fistula with high-output cardiac failure. Surg Laparosc Endosc Percutan Tech 2001;11:334-337.
29. Zalts R, Hayek T. A large arteriovenous fistula between the femoral artery and the femoral vein after cardiac catheterization manifesting as high-output cardiac failure. Am J Med Sci 2005;330:150-152.
30. Ruebben A, Tettoni S, Muratore P, et al. Arteriovenous fistulas induced by femoral arterial catheterization: Percutaneous treatment. Radiology 1998;209:729-734.
31. Slaba S, Younan T, Karam P, et al. Arteriovenous fistula following femoral angioplasty. J Radiol 1999;80:945-947.
32. Grier D, Hartnell G. Percutaneous femoral artery puncture: Practice and anatomy. Br J Radiol 1990;63:602-604.
33. Altin RS, Flicker S, Naidech HJ. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: Association with low femoral punctures. AJR Am J Roentgenol 1989;152:629-631.
34. Schaub F, Theiss W, Heinz M, et al. New aspects in ultrasound guided compression repair of postcatheterization femoral artery injuries. Circulation 1994;90:1861-1865.
35. Fellmeth BD, Roberts AC, Bookstein JJ, et al. Postangiographic femoral artery injuries: Nonsurgical repair with US guided compression. Radiology 1991;178:671-675.
36. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63-68.
37. Thalhammer C, Kirchherr AS, Waigand J, et al. Postcatheterization pseudoaneurysms and arteriovenous fistulas: Repair with percutaneous implantation of endovascular covered stents. Radiology 2000;214:127-131.
38. Sommer C, Ferbert A. Damage to the lateral cutaneous femoral nerve after transfemoral angiography. Nervenarzt 1992;63:633-635.
39. Enomae M, Takeda S, Yoshimoto K, Takagawa K. Chronic cholesterol crystal embolism with a spontaneous onset. Intern Med 2007;46:1123-1126.
40. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: A prospective study. J Am Coll Cardiol 2003;42:211-216.
41. Blankenship JC, Butler M, Garbes A. Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 1995;107:662-668.
42. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 1987;38:769-784.
43. Bittl JA. Cholesterol embolization syndrome: Unifying principles. Catheter Cardiovasc Interv 2000;51:326-327.
44. Tamura K, Umemura M, Yano H, et al. Acute renal failure due tcholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol 2003;7:67-71.
45. Tsunoda S, Daimon S, Miyazaki R, et al. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. Nephrol Dial Transplant 1999;14:1041-1042.
46. Fink AN, Frishman WH, Azizad M, Agarwal Y. Use of prostacyclin and its analogues in the treatment of cardiovascular disease. Heart Dis 1999;1:29-40.
47. Scorza R, Rivolta R, Mascagni B, et al. Effect of iloprost infusion on resistance index of patients with systemic sclerosis. J Rheumatol 1997; 24:1944-1948.
48. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 2002;324:268-269.
49. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998;53:230-242.
50. Agrawal M, Stouffer GA. Cardiology Grand Rounds from the University of North Carolina at Chapel Hill. Contrast induced nephropathy after angiography. Am J Med Sci 2002;323:252-258.
51. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-182.
52. Lindholt JS. Radiocontrast induced nephropathy. Eur J Vasc Endovasc Surg 2003;25:296-304.
53. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
54. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004;44:1393-1399.
55. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
56. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22.
57. Bader BD, Berger ED, Heede MB, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 2004;62:1-7.
58. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336.
59. From AM, Bartholmai BJ, Williams AW, et al. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol 2008;3:10-18.
60. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251-260.
61. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004;65:1366-1374.
62. Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: Comprehensive meta-analysis. Catheter Cardiovasc Interv 2005;64:471-479.
63. Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radio-contrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004;15:761-769.
64. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-2842.
65. Bagshaw SM, Ghali WA. Theophylline for prevention of contrast-induced nephropathy: A systematic review and meta-analysis. Arch Intern Med 2005;165:1087-1093.
66. Khoury Z, Schlicht JR, Como J, et al. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy 1995;15:59-65.
67. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 1999;34:1682-1688.
68. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial. JAMA 2003;290:2284-2291.
69. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.
70. Jo SH, Youn TJ, Koo BK, et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: The RECOVER study: A randomized controlled trial. J Am Coll Cardiol 2006;48:924-930.
71. McCullough PA, Bertrand ME, Brinker JA, et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006;48:692-699.
72. Solomon RJ, Natarajan MK, Doucet S, et al, Investigators of the CARE Study. Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007;115:3189-3196.
73. Liss P, Persson PB, Hansell P, et al. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.Kidney Int 2006;70:1811-1817.
74. Khatri P, Kasner SE. Ischemic strokes after cardiac catheterization: Opportune thrombolysis candidates? Arch Neurol 2006:63;817-821.
75. Kissela BM, Kothari RU, Tomsick TA, et al. Embolization of calcific thrombi after tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis 2001;10:135-138.
76. Khatri P, Taylor RA, Palumbo V, et al. Treatment of Acute Stroke after Cardiac Catheterization (TASCC) Study Group. The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol 2008;51:906-911.